These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 14597993)
1. ADAMTS 13 genotype and vWF protease activity in an Italian family with TTP. Bestetti G; Stellari A; Lattuada A; Corbellino M; Parravicini C; Calzarossa C; Cenzuales S; Moroni M; Galli M; Rossi E Thromb Haemost; 2003 Nov; 90(5):955-6. PubMed ID: 14597993 [No Abstract] [Full Text] [Related]
2. [From gene to disease; congenital thrombotic thrombocytopenic purpura due to mutations in the ADAMTS13 gene]. Schiphorst RH; van de Kar NC; van den Heuvel LP Ned Tijdschr Geneeskd; 2003 Dec; 147(49):2422-4. PubMed ID: 14694551 [TBL] [Abstract][Full Text] [Related]
3. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Tsai HM J Mol Med (Berl); 2002 Oct; 80(10):639-47. PubMed ID: 12395148 [TBL] [Abstract][Full Text] [Related]
4. Genetic defects leading to hereditary thrombotic thrombocytopenic purpura. Kokame K; Miyata T Semin Hematol; 2004 Jan; 41(1):34-40. PubMed ID: 14727257 [TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura. Peyvandi F; Ferrari S; Lavoretano S; Canciani MT; Mannucci PM Br J Haematol; 2004 Nov; 127(4):433-9. PubMed ID: 15521921 [TBL] [Abstract][Full Text] [Related]
7. [TTP/HUS and VWF/ADAMTS-13]. Fujimura Y Rinsho Ketsueki; 2003 Dec; 44(12):1144-53. PubMed ID: 14978930 [No Abstract] [Full Text] [Related]
8. ADAMTS13 gene mutation in congenital thrombotic thrombocytopenic purpura with previously reported normal VWF cleaving protease activity. Savasan S; Lee SK; Ginsburg D; Tsai HM Blood; 2003 Jun; 101(11):4449-51. PubMed ID: 12576319 [TBL] [Abstract][Full Text] [Related]
9. An enzyme immunoassay of ADAMTS13 distinguishes patients with thrombotic thrombocytopenic purpura from normal individuals and carriers of ADAMTS13 mutations. Zhou W; Tsai HM Thromb Haemost; 2004 Apr; 91(4):806-11. PubMed ID: 15045144 [TBL] [Abstract][Full Text] [Related]
10. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13. Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154 [TBL] [Abstract][Full Text] [Related]
11. Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity. Kokame K; Matsumoto M; Soejima K; Yagi H; Ishizashi H; Funato M; Tamai H; Konno M; Kamide K; Kawano Y; Miyata T; Fujimura Y Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11902-7. PubMed ID: 12181489 [TBL] [Abstract][Full Text] [Related]
13. Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13. Pimanda JE; Maekawa A; Wind T; Paxton J; Chesterman CN; Hogg PJ Blood; 2004 Jan; 103(2):627-9. PubMed ID: 14512317 [TBL] [Abstract][Full Text] [Related]
14. Expression and characterization of recombinant human ADAMTS-13. Plaimauer B; Scheiflinger F Semin Hematol; 2004 Jan; 41(1):24-33. PubMed ID: 14727256 [TBL] [Abstract][Full Text] [Related]
15. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Furlan M; Robles R; Galbusera M; Remuzzi G; Kyrle PA; Brenner B; Krause M; Scharrer I; Aumann V; Mittler U; Solenthaler M; Lämmle B N Engl J Med; 1998 Nov; 339(22):1578-84. PubMed ID: 9828245 [TBL] [Abstract][Full Text] [Related]
16. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Levy GG; Nichols WC; Lian EC; Foroud T; McClintick JN; McGee BM; Yang AY; Siemieniak DR; Stark KR; Gruppo R; Sarode R; Shurin SB; Chandrasekaran V; Stabler SP; Sabio H; Bouhassira EE; Upshaw JD; Ginsburg D; Tsai HM Nature; 2001 Oct; 413(6855):488-94. PubMed ID: 11586351 [TBL] [Abstract][Full Text] [Related]
17. [Activity loss of Von Willebrand factor cleaving protein (ADAMTS-13) is diagnostic for primary and pregnancy-related thrombotic thrombocytopenic purpura]. Hulstein JJ; Rison CN; Kappers-Klunne MC; Hene RJ; Franx A; de Groot PG; Brand A; Fijnheer R Ned Tijdschr Geneeskd; 2004 Oct; 148(40):1972-6. PubMed ID: 15524133 [TBL] [Abstract][Full Text] [Related]
18. The role of ADAMTS13 in the pathogenesis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. George JN Clin Adv Hematol Oncol; 2005 Aug; 3(8):627-32. PubMed ID: 16167049 [TBL] [Abstract][Full Text] [Related]
19. Dissociation between the level of von Willebrand factor-cleaving protease activity and disease in a patient with congenital thrombotic thrombocytopenic purpura. Snider CE; Moore JC; Warkentin TE; Finch CN; Hayward CP; Kelton JG Am J Hematol; 2004 Dec; 77(4):387-90. PubMed ID: 15551280 [TBL] [Abstract][Full Text] [Related]
20. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]